Pluri's patent enables mass-scale production of immune cell therapiesNew patented technology is applicable for the expansion of a variety of immune cellsTechnology sets stage for potential immune cell...
International Coffee Organization (ICO) Market Report published on March 7, 2024 highlights alarming price instability challenging the coffee industryAccording to the report, adverse weather...
Pluri Selected as CDMO by Remedy Cell for Cell-Free Drug Manufacturing
Pluri Receives First-Ever Patent Approval for 3D Bioreactor Technology
Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board
Growing pipeline of industry-specific new potential products, services, collaborations and partnerships through PluriAgtech, PluriCDMO, PluriHealth, and PluriFoodRecent achievements include: new...
Pluri to leverage its proprietary 3D technology platform to develop cell-based products for the coffee industry under its new business vertical PluriAgtechThe rapidly growing $130 billion coffee...